<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <billType>S</billType>
    <updateDate>2017-06-02T22:46:17Z</updateDate>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Crimes against property</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Intellectual property</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Crime and Law Enforcement</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <policyArea>
      <name>Crime and Law Enforcement</name>
    </policyArea>
    <laws>
      <item>
        <number>114-154</number>
        <type>Public Law</type>
      </item>
    </laws>
    <version>1.0.0</version>
    <amendments />
    <calendarNumbers>
      <item>
        <number>0232</number>
        <calendar>Senate Calendar of Business</calendar>
      </item>
    </calendarNumbers>
    <relatedBills>
      <item>
        <type>HR</type>
        <latestAction>
          <text>Placed on the Union Calendar, Calendar No. 469.</text>
          <actionDate>2016-06-03</actionDate>
        </latestAction>
        <congress>114</congress>
        <number>3380</number>
        <latestTitle>Transnational Drug Trafficking Act of 2015</latestTitle>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
          <item>
            <type>Related bill</type>
            <identifiedBy>House</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <type>S</type>
        <latestAction>
          <text>Became Public Law No: 114-198.</text>
          <actionDate>2016-07-22</actionDate>
        </latestAction>
        <congress>114</congress>
        <number>524</number>
        <latestTitle>Comprehensive Addiction and Recovery Act of 2016</latestTitle>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <introducedDate>2015-01-06</introducedDate>
    <notes />
    <latestAction>
      <text>Became Public Law No: 114-154.</text>
      <actionDate>2016-05-16</actionDate>
      <links>
        <link>
          <name>Public Law No: 114-154</name>
          <url>https://www.congress.gov/bill/114th-congress/senate-bill/32/text/pl</url>
        </link>
      </links>
    </latestAction>
    <originChamber>Senate</originChamber>
    <sponsors>
      <item>
        <identifiers>
          <bioguideId>F000062</bioguideId>
          <gpoId>8338</gpoId>
          <lisID>1332</lisID>
        </identifiers>
        <firstName>DIANNE</firstName>
        <bioguideId>F000062</bioguideId>
        <middleName />
        <byRequestType />
        <state>CA</state>
        <fullName>Sen. Feinstein, Dianne [D-CA]</fullName>
        <party>D</party>
        <lastName>FEINSTEIN</lastName>
      </item>
    </sponsors>
    <recordedVotes />
    <billNumber>32</billNumber>
    <titles>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType>Short Title</parentTitleType>
        <titleType>Short Titles as Enacted</titleType>
        <title>Transnational Drug Trafficking Act of 2015</title>
      </item>
      <item>
        <chamberName>Senate</chamberName>
        <chamberCode>S</chamberCode>
        <parentTitleType>Short Titles Senate</parentTitleType>
        <titleType>Short Titles as Passed Senate</titleType>
        <title>Transnational Drug Trafficking Act of 2015</title>
      </item>
      <item>
        <chamberName>House</chamberName>
        <chamberCode>H</chamberCode>
        <parentTitleType>Short Titles House of Representatives</parentTitleType>
        <titleType>Short Titles as Passed House</titleType>
        <title>Transnational Drug Trafficking Act of 2015</title>
      </item>
      <item>
        <chamberName>Senate</chamberName>
        <chamberCode>S</chamberCode>
        <parentTitleType>Short Titles Senate</parentTitleType>
        <titleType>Short Titles as Reported to Senate</titleType>
        <title>Transnational Drug Trafficking Act of 2015</title>
      </item>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <title>Transnational Drug Trafficking Act of 2015</title>
      </item>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to provide the Department of Justice with additional tools to target extraterritorial drug trafficking activity, and for other purposes.</title>
      </item>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Display Title</titleType>
        <title>Transnational Drug Trafficking Act of 2015</title>
      </item>
    </titles>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <updateDate>2015-01-06T05:00:00Z</updateDate>
          <text><![CDATA[<p><b>Transnational Drug Trafficking Act of 2015</b></p> <p> Amends the Controlled Substances Import and Export Act to prohibit the manufacture or distribution of a controlled substance in schedule I or II, flunitrazepam, or a listed chemical by individuals having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within 12 miles of the U.S. coast.</p> <p>Prohibits the manufacture or distribution of a listed chemical: (1) intending or knowing that it will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the substance will be unlawfully imported into the United States. </p> <p>Amends the federal criminal code to revise the prohibition against, and penalties for, intentionally trafficking in a counterfeit drug to apply to intentionally trafficking in a drug and knowingly using a counterfeit mark on or in connection with such drug.</p>]]></text>
          <name>Introduced in Senate</name>
          <lastSummaryUpdateDate>2015-01-14T16:43:36Z</lastSummaryUpdateDate>
          <actionDesc>Introduced in Senate</actionDesc>
          <actionDate>2015-01-06</actionDate>
        </item>
        <item>
          <versionCode>80</versionCode>
          <updateDate>2015-09-17T12:28:21Z</updateDate>
          <text><![CDATA[<p>(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)</p> <p><b>Transnational Drug Trafficking Act of 2015</b></p> <p>(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence. </p> <p>Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported. </p> <p>In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States. </p> <p>(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."</p>]]></text>
          <name>Reported to Senate without amendment</name>
          <lastSummaryUpdateDate>2016-06-03T20:01:54Z</lastSummaryUpdateDate>
          <actionDesc>Reported to Senate without amendment</actionDesc>
          <actionDate>2015-09-17</actionDate>
        </item>
        <item>
          <versionCode>82</versionCode>
          <updateDate>2015-10-07T12:06:35Z</updateDate>
          <text><![CDATA[<p>(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)</p> <p><b>Transnational Drug Trafficking Act of 2015</b></p> <p>(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence. </p> <p>Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported. </p> <p>In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States. </p> <p>(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."</p>]]></text>
          <name>Passed Senate without amendment</name>
          <lastSummaryUpdateDate>2016-06-07T17:08:15Z</lastSummaryUpdateDate>
          <actionDesc>Passed Senate without amendment</actionDesc>
          <actionDate>2015-10-07</actionDate>
        </item>
        <item>
          <versionCode>81</versionCode>
          <updateDate>2016-05-10T14:32:34Z</updateDate>
          <text><![CDATA[<p>(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)</p> <p><b>Transnational Drug Trafficking Act of 2015</b></p> <p>(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence. </p> <p>Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported. </p> <p>In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States. </p> <p>(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."</p>]]></text>
          <name>Passed House without amendment</name>
          <lastSummaryUpdateDate>2016-06-08T18:04:20Z</lastSummaryUpdateDate>
          <actionDesc>Passed House without amendment</actionDesc>
          <actionDate>2016-05-10</actionDate>
        </item>
        <item>
          <versionCode>49</versionCode>
          <updateDate>2016-05-17T03:59:59Z</updateDate>
          <text><![CDATA[<p>(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)</p> <p><b>Transnational Drug Trafficking Act of 2015</b></p> <p>(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence.</p> <p>Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported.</p> <p>In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States.</p> <p>(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."</p>]]></text>
          <name>Public Law</name>
          <lastSummaryUpdateDate>2016-07-18T21:25:30Z</lastSummaryUpdateDate>
          <actionDesc>Public Law</actionDesc>
          <actionDate>2016-05-16</actionDate>
        </item>
      </billSummaries>
    </summaries>
    <congress>114</congress>
    <committeeReports />
    <title>Transnational Drug Trafficking Act of 2015</title>
    <cboCostEstimates>
      <item>
        <pubDate>2015-09-28T20:53:26Z</pubDate>
        <title>S. 32, Transnational Drug Trafficking Act of 2015</title>
        <url>https://www.cbo.gov/publication/50848</url>
      </item>
    </cboCostEstimates>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>12</houseOfRepresentatives>
        <senate>13</senate>
      </actionByCounts>
      <item>
        <links>
          <link>
            <name>Public Law No: 114-154</name>
            <url>http://tntwxavlp01.loc.gov/bill/114th-congress/senate-bill/32/text/pl</url>
          </link>
        </links>
        <type>President</type>
        <actionCode>E40000</actionCode>
        <actionDate>2016-05-16</actionDate>
        <committee />
        <text>Became Public Law No: 114-154.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <links>
          <link>
            <name>Public Law No: 114-154</name>
            <url>http://tntwxavlp01.loc.gov/bill/114th-congress/senate-bill/32/text/pl</url>
          </link>
        </links>
        <type>BecameLaw</type>
        <actionCode>36000</actionCode>
        <actionDate>2016-05-16</actionDate>
        <committee />
        <text>Became Public Law No: 114-154.</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <item>
        <links />
        <type>President</type>
        <actionCode>E30000</actionCode>
        <actionDate>2016-05-16</actionDate>
        <committee />
        <text>Signed by President.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <links />
        <type>BecameLaw</type>
        <actionCode>36000</actionCode>
        <actionDate>2016-05-16</actionDate>
        <committee />
        <text>Signed by President.</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <item>
        <links />
        <type>Floor</type>
        <actionCode>E20000</actionCode>
        <actionDate>2016-05-13</actionDate>
        <committee />
        <text>Presented to President.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <links />
        <type>President</type>
        <actionCode>28000</actionCode>
        <actionDate>2016-05-13</actionDate>
        <committee />
        <text>Presented to President.</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <item>
        <actionTime>16:54:27</actionTime>
        <links />
        <type>Floor</type>
        <actionCode>H38310</actionCode>
        <actionDate>2016-05-10</actionDate>
        <committee />
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <actionTime>16:54:26</actionTime>
        <links>
          <link>
            <name>H2175</name>
            <url>https://www.congress.gov/congressional-record/volume-162/house-section/page/H2175</url>
          </link>
        </links>
        <type>Floor</type>
        <actionCode>H37300</actionCode>
        <actionDate>2016-05-10</actionDate>
        <committee />
        <text>On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2175)</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <actionTime>16:54:26</actionTime>
        <links>
          <link>
            <name>H2175</name>
            <url>http://tntwxavlp01.loc.gov/congressional-record/volume-162/house-section/page/H2175</url>
          </link>
        </links>
        <type>Floor</type>
        <actionCode>8000</actionCode>
        <actionDate>2016-05-10</actionDate>
        <committee />
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H2175)</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <item>
        <actionTime>16:30:57</actionTime>
        <links>
          <link>
            <name>S. 32</name>
            <url>https://www.congress.gov/bill/114th-congress/senate-bill/32</url>
          </link>
        </links>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
        <actionDate>2016-05-10</actionDate>
        <committee />
        <text>DEBATE - The House proceeded with forty minutes of debate on S. 32.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <actionTime>16:30:55</actionTime>
        <links>
          <link>
            <name>H2175-2179</name>
            <url>https://www.congress.gov/congressional-record/volume-162/house-section/page/H2175-2179</url>
          </link>
        </links>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <actionDate>2016-05-10</actionDate>
        <committee />
        <text>Considered under suspension of the rules. (consideration: CR H2175-2179)</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <actionTime>16:30:46</actionTime>
        <links />
        <type>Floor</type>
        <actionCode>H30300</actionCode>
        <actionDate>2016-05-10</actionDate>
        <committee />
        <text>Mr. Goodlatte moved to suspend the rules and pass the bill.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-11-17</actionDate>
        <committee>
          <systemCode>scnc00</systemCode>
          <name>Senate Narcotics Caucus Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Committee on United States Senate Caucus on International Narcotics Control. Hearings held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2015-11-03</actionDate>
        <committee>
          <systemCode>hsju08</systemCode>
          <name>Crime, Terrorism, Homeland Security, and Investigations Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2015-10-09</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <links />
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <actionDate>2015-10-08</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <text>Referred to House Energy and Commerce</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <links />
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <actionDate>2015-10-08</actionDate>
        <committee>
          <systemCode>hsju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <text>Referred to House Judiciary</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <links />
        <type>IntroReferral</type>
        <actionCode>H11100-A</actionCode>
        <actionDate>2015-10-08</actionDate>
        <committee />
        <text>Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-10-08</actionDate>
        <committee />
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Message on Senate action sent to the House.</text>
        <type>Floor</type>
      </item>
      <item>
        <actionTime>12:01:51</actionTime>
        <links />
        <type>Floor</type>
        <actionCode>H14000</actionCode>
        <actionDate>2015-10-08</actionDate>
        <committee />
        <text>Received in the House.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-10-07</actionDate>
        <committee />
        <links>
          <link>
            <name>S7223</name>
            <url>https://www.congress.gov/congressional-record/volume-161/senate-section/page/S7223</url>
          </link>
        </links>
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Passed Senate without amendment by Unanimous Consent. (consideration: CR S7223; text as passed Senate: CR S7223)</text>
        <type>Floor</type>
      </item>
      <item>
        <links>
          <link>
            <name>S7223</name>
            <url>http://tntwxavlp01.loc.gov/congressional-record/volume-161/senate-section/page/S7223</url>
          </link>
        </links>
        <type>Floor</type>
        <actionCode>17000</actionCode>
        <actionDate>2015-10-07</actionDate>
        <committee />
        <text>Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S7223; text as passed Senate: CR S7223)</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-09-17</actionDate>
        <committee />
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 232.</text>
        <type>Calendars</type>
      </item>
      <item>
        <actionDate>2015-09-17</actionDate>
        <committee>
          <systemCode>ssju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.</text>
        <type>Committee</type>
      </item>
      <item>
        <links />
        <type>Committee</type>
        <actionCode>14000</actionCode>
        <actionDate>2015-09-17</actionDate>
        <committee>
          <systemCode>ssju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <text>Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-09-17</actionDate>
        <committee>
          <systemCode>ssju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Committee on the Judiciary. Ordered to be reported without amendment favorably.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2015-01-13</actionDate>
        <committee>
          <systemCode>ssju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Referred to the Committee on the Judiciary by unanimous consent.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2015-01-13</actionDate>
        <committee>
          <systemCode>ssfi00</systemCode>
          <name>Finance Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Senate Committee on Finance discharged by Unanimous Consent.</text>
        <type>Discharge</type>
      </item>
      <item>
        <links />
        <type>Committee</type>
        <actionCode>14500</actionCode>
        <actionDate>2015-01-13</actionDate>
        <committee>
          <systemCode>ssfi00</systemCode>
          <name>Finance Committee</name>
        </committee>
        <text>Senate Committee on Finance discharged by Unanimous Consent.</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-01-06</actionDate>
        <committee>
          <systemCode>ssfi00</systemCode>
          <name>Finance Committee</name>
        </committee>
        <links>
          <link>
            <name>S18-19</name>
            <url>https://www.congress.gov/congressional-record/volume-161/senate-section/page/S18-19</url>
          </link>
        </links>
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S18-19)</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <links />
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <actionDate>2015-01-06</actionDate>
        <committee />
        <text>Introduced in Senate</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <actionTypeCounts>
        <placeholderTextForE>3</placeholderTextForE>
        <passedSenate>1</passedSenate>
        <generalDebate>1</generalDebate>
        <receivedInTheHouse>1</receivedInTheHouse>
        <senateCommitteeDischarged>1</senateCommitteeDischarged>
        <passedAgreedToInHouse>1</passedAgreedToInHouse>
        <motionToReconsiderResults>1</motionToReconsiderResults>
        <presentedToPresident>1</presentedToPresident>
        <billReferralsAggregate>1</billReferralsAggregate>
        <billReferrals>2</billReferrals>
        <committeeDischarged>1</committeeDischarged>
        <orderedReported>1</orderedReported>
        <passedAgreedToInSenate>1</passedAgreedToInSenate>
        <placedOnCalendarGeneralOrders>1</placedOnCalendarGeneralOrders>
        <becamePublicLaw>2</becamePublicLaw>
        <finalPassageUnderSuspensionOfTheRulesResults>1</finalPassageUnderSuspensionOfTheRulesResults>
        <sentToHouse>1</sentToHouse>
        <hearingsHeld>1</hearingsHeld>
        <placeholderTextForH>2</placeholderTextForH>
        <considerationByHouse>1</considerationByHouse>
        <reportedToSenate>2</reportedToSenate>
        <introducedInSenate>1</introducedInSenate>
        <motionMadeToSuspendTheRules>1</motionMadeToSuspendTheRules>
        <referredToCommittee>2</referredToCommittee>
      </actionTypeCounts>
    </actions>
    <createDate>2015-01-07T08:31:10Z</createDate>
    <cosponsors>
      <item>
        <sponsorshipDate>2015-01-06</sponsorshipDate>
        <state>NM</state>
        <middleName />
        <sponsorshipWithdrawnDate />
        <firstName>TOM</firstName>
        <lastName>UDALL</lastName>
        <identifiers>
          <bioguideId>U000039</bioguideId>
          <gpoId>8260</gpoId>
          <lisID>1567</lisID>
        </identifiers>
        <bioguideId>U000039</bioguideId>
        <party>D</party>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Sen. Udall, Tom [D-NM]</fullName>
      </item>
      <item>
        <sponsorshipDate>2015-01-06</sponsorshipDate>
        <state>CT</state>
        <middleName />
        <sponsorshipWithdrawnDate />
        <firstName>Richard</firstName>
        <lastName>Blumenthal</lastName>
        <identifiers>
          <lisID>2076</lisID>
          <gpoId>8332</gpoId>
          <bioguideId>B001277</bioguideId>
        </identifiers>
        <bioguideId>B001277</bioguideId>
        <party>D</party>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Sen. Blumenthal, Richard [D-CT]</fullName>
      </item>
      <item>
        <sponsorshipDate>2015-01-06</sponsorshipDate>
        <state>MN</state>
        <middleName />
        <sponsorshipWithdrawnDate />
        <firstName>Amy</firstName>
        <lastName>Klobuchar</lastName>
        <identifiers>
          <lisID>1826</lisID>
          <gpoId>8249</gpoId>
          <bioguideId>K000367</bioguideId>
        </identifiers>
        <bioguideId>K000367</bioguideId>
        <party>D</party>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Sen. Klobuchar, Amy [D-MN]</fullName>
      </item>
      <item>
        <sponsorshipDate>2015-01-06</sponsorshipDate>
        <state>IA</state>
        <middleName>ERNEST</middleName>
        <sponsorshipWithdrawnDate />
        <firstName>CHARLES</firstName>
        <lastName>GRASSLEY</lastName>
        <identifiers>
          <bioguideId>G000386</bioguideId>
          <gpoId>8316</gpoId>
          <lisID>457</lisID>
        </identifiers>
        <bioguideId>G000386</bioguideId>
        <party>R</party>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Sen. Grassley, Chuck [R-IA]</fullName>
      </item>
      <item>
        <sponsorshipDate>2015-01-06</sponsorshipDate>
        <state>ND</state>
        <middleName />
        <sponsorshipWithdrawnDate />
        <firstName>Heidi</firstName>
        <lastName>Heitkamp</lastName>
        <identifiers>
          <gpoId />
          <bioguideId>H001069</bioguideId>
          <lisID>2174</lisID>
        </identifiers>
        <bioguideId>H001069</bioguideId>
        <party>D</party>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Sen. Heitkamp, Heidi [D-ND]</fullName>
      </item>
      <item>
        <sponsorshipDate>2015-07-27</sponsorshipDate>
        <state>TX</state>
        <middleName />
        <sponsorshipWithdrawnDate />
        <firstName>John</firstName>
        <lastName>Cornyn</lastName>
        <identifiers>
          <lisID>1692</lisID>
          <gpoId>8295</gpoId>
          <bioguideId>C001056</bioguideId>
        </identifiers>
        <bioguideId>C001056</bioguideId>
        <party>R</party>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Sen. Cornyn, John [R-TX]</fullName>
      </item>
      <item>
        <sponsorshipDate>2015-07-27</sponsorshipDate>
        <state>NY</state>
        <middleName>E.</middleName>
        <sponsorshipWithdrawnDate />
        <firstName>CHARLES</firstName>
        <lastName>SCHUMER</lastName>
        <identifiers>
          <gpoId>8279</gpoId>
          <bioguideId>S000148</bioguideId>
          <lisID>1036</lisID>
        </identifiers>
        <bioguideId>S000148</bioguideId>
        <party>D</party>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Sen. Schumer, Charles E. [D-NY]</fullName>
      </item>
      <item>
        <sponsorshipDate>2015-07-27</sponsorshipDate>
        <state>NH</state>
        <middleName />
        <sponsorshipWithdrawnDate />
        <firstName>Kelly</firstName>
        <lastName>Ayotte</lastName>
        <identifiers>
          <lisID>2075</lisID>
          <gpoId>8315</gpoId>
          <bioguideId>A000368</bioguideId>
        </identifiers>
        <bioguideId>A000368</bioguideId>
        <party>R</party>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Sen. Ayotte, Kelly [R-NH]</fullName>
      </item>
      <item>
        <sponsorshipDate>2015-09-17</sponsorshipDate>
        <state>DE</state>
        <middleName>A.</middleName>
        <sponsorshipWithdrawnDate />
        <firstName>Christopher</firstName>
        <lastName>Coons</lastName>
        <identifiers>
          <bioguideId>C001088</bioguideId>
          <gpoId>8297</gpoId>
          <lisID>1984</lisID>
        </identifiers>
        <bioguideId>C001088</bioguideId>
        <party>D</party>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Sen. Coons, Christopher A. [D-DE]</fullName>
      </item>
    </cosponsors>
    <committees>
      <billCommittees>
        <item>
          <systemCode>scnc00</systemCode>
          <type>Other</type>
          <subcommittees />
          <name>Senate Narcotics Caucus Committee</name>
          <chamber>Senate</chamber>
          <activities>
            <item>
              <date>2015-11-17T15:00:00Z</date>
              <name>Hearings by</name>
            </item>
          </activities>
        </item>
        <item>
          <systemCode>hsju00</systemCode>
          <type>Standing</type>
          <subcommittees>
            <item>
              <name>Crime, Terrorism, Homeland Security, and Investigations Subcommittee</name>
              <systemCode>hsju08</systemCode>
              <activities>
                <item>
                  <date>2015-11-03T18:43:06Z</date>
                  <name>Referred to</name>
                </item>
              </activities>
            </item>
          </subcommittees>
          <name>Judiciary Committee</name>
          <chamber>House</chamber>
          <activities>
            <item>
              <date>2015-10-08T21:21:28Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
        <item>
          <systemCode>hsif00</systemCode>
          <type>Standing</type>
          <subcommittees>
            <item>
              <name>Health Subcommittee</name>
              <systemCode>hsif14</systemCode>
              <activities>
                <item>
                  <date>2015-10-09T21:43:53Z</date>
                  <name>Referred to</name>
                </item>
              </activities>
            </item>
          </subcommittees>
          <name>Energy and Commerce Committee</name>
          <chamber>House</chamber>
          <activities>
            <item>
              <date>2015-10-08T21:21:29Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
        <item>
          <systemCode>ssju00</systemCode>
          <type>Standing</type>
          <subcommittees />
          <name>Judiciary Committee</name>
          <chamber>Senate</chamber>
          <activities>
            <item>
              <date>2015-09-17T16:34:57Z</date>
              <name>Reported by</name>
            </item>
            <item>
              <date>2015-09-17T14:34:08Z</date>
              <name>Markup by</name>
            </item>
            <item>
              <date>2015-01-13T23:37:00Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
        <item>
          <systemCode>ssfi00</systemCode>
          <type>Standing</type>
          <subcommittees />
          <name>Finance Committee</name>
          <chamber>Senate</chamber>
          <activities>
            <item>
              <date>2015-01-13T23:36:53Z</date>
              <name>Discharged from</name>
            </item>
            <item>
              <date>2015-01-06T21:16:59Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

